Search results for robert-f-hillary_prevalent_type_2_diabetes_(self-report)_fully-adjusted_model
Author | PMID | Outcome | Exposure | Tissue | Analysis | N | CpG | Location | Gene | Beta | P |
---|---|---|---|---|---|---|---|---|---|---|---|
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg19693031 | chr1:145441552 | TXNIP | -0.19 | 1.8E-53 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg06500161 | chr21:43656587 | ABCG1 | 0.29 | 4.2E-33 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg17901584 | chr1:55353706 | DHCR24 | -0.19 | 4.3E-30 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg15659943 | chr9:107631656 | ABCA1 | 0.28 | 3.5E-26 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg02988288 | chr1:145440445 | TXNIP;NBPF20;NBPF10 | -0.12 | 9.6E-25 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg26974062 | chr1:145440734 | TXNIP;NBPF20;NBPF10 | -0.11 | 3.8E-22 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg15128785 | chr22:42230879 | SREBF2 | -0.12 | 6.9E-18 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg00857282 | chr6:16130727 | MYLIP | 0.09 | 1.5E-17 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg17058475 | chr11:68607737 | CPT1A | -0.098 | 1.2E-16 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg27243685 | chr21:43642366 | ABCG1 | 0.15 | 1.7E-16 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg10128003 | chr21:43642166 | ABCG1 | 0.15 | 1.8E-16 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg19266329 | chr1:145456128 | - | -0.15 | 3.5E-15 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg24694018 | chr1:145457621 | POLR3GL | -0.18 | 1.9E-14 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg05119988 | chr4:166251189 | SC4MOL | -0.12 | 6.4E-14 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg05028010 | chr1:145437567 | TXNIP;NBPF20;NBPF10 | -0.11 | 2.6E-13 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg05014727 | chr10:6214016 | PFKFB3 | -0.096 | 5.2E-13 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg08309687 | chr21:35320596 | - | -0.11 | 6.6E-13 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg16740586 | chr21:43655919 | ABCG1 | 0.13 | 2.1E-12 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg26262157 | chr10:6214079 | PFKFB3 | -0.099 | 2.7E-12 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg01881899 | chr21:43652704 | ABCG1 | 0.093 | 2.8E-12 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg12403973 | chr22:42230899 | SREBF2 | -0.086 | 4.2E-12 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg05325763 | chr11:68607719 | CPT1A | -0.086 | 4.4E-12 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg09063556 | chr16:66653795 | CMTM4 | 0.14 | 4.9E-12 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg26823705 | chr1:145435523 | NBPF20;NBPF10 | -0.1 | 5.9E-12 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg06690548 | chr4:139162808 | SLC7A11 | -0.072 | 6E-12 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg20003499 | chr7:97755792 | LMTK2 | 0.12 | 6.3E-12 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg09627709 | chr7:97755719 | LMTK2 | 0.12 | 6.4E-12 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg08088075 | chr2:220264753 | - | 0.15 | 7.7E-12 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg00014380 | chr16:4424290 | VASN;CORO7-PAM16;CORO7 | 0.11 | 1.6E-11 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg22652934 | chr21:36180035 | RUNX1 | -0.093 | 1.6E-11 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg03685481 | chr15:51066872 | - | 0.11 | 2.6E-11 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg00994936 | chr19:1423902 | DAZAP1 | 0.089 | 3.2E-11 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg16395997 | chr1:3562798 | WDR8 | 0.12 | 4.5E-11 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg15043602 | chr17:17079454 | MPRIP | 0.17 | 1E-10 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg00574958 | chr11:68607622 | CPT1A | -0.088 | 1.9E-10 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg14115749 | chr19:19596444 | GATAD2A | 0.17 | 2.5E-10 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg07458272 | chr19:34744396 | KIAA0355 | 0.12 | 3.6E-10 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg11024682 | chr17:17730094 | SREBF1 | 0.15 | 3.6E-10 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg04695090 | chr22:38609508 | MAFF | 0.17 | 9.5E-10 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg08994060 | chr10:6214026 | PFKFB3 | -0.071 | 9.9E-10 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg07719604 | chr16:67232460 | ELMO3;E2F4 | 0.13 | 1.1E-09 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg14476101 | chr1:120255992 | PHGDH | -0.078 | 1.1E-09 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg27216853 | chr2:10205672 | CYS1 | 0.13 | 1.3E-09 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg01676795 | chr7:75586348 | POR | 0.11 | 1.4E-09 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg19750657 | chr13:38935967 | UFM1 | 0.097 | 1.5E-09 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg14597545 | chr15:73074210 | ADPGK | 0.12 | 1.5E-09 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg06045838 | chr17:26670995 | TNFAIP1 | 0.18 | 1.6E-09 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg07198997 | chr1:24120115 | LYPLA2 | 0.14 | 1.9E-09 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg02770216 | chr7:91687079 | AKAP9 | 0.077 | 1.9E-09 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg11183227 | chr15:91455407 | MAN2A2 | 0.072 | 2E-09 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg10821511 | chr17:47286445 | GNGT2;ABI3 | 0.2 | 2.2E-09 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg06214651 | chr18:11980037 | IMPA2 | -0.11 | 2.5E-09 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg13030981 | chr11:3859306 | RHOG | -0.087 | 2.7E-09 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg03241987 | chr9:755891 | - | -0.068 | 2.8E-09 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg03637691 | chr19:11202610 | LDLR | -0.085 | 3E-09 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg18280125 | chr4:4427113 | STX18 | 0.064 | 3.4E-09 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg04816311 | chr7:1066650 | C7orf50 | 0.087 | 4.1E-09 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg06710464 | chr17:79047695 | BAIAP2 | 0.11 | 5.3E-09 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg02841972 | chr2:10176151 | - | -0.12 | 5.4E-09 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg01406381 | chr19:47288263 | SLC1A5 | -0.065 | 5.4E-09 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg11491284 | chr3:141888226 | GK5 | -0.11 | 7.4E-09 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg01004980 | chr3:48883069 | PRKAR2A | 0.11 | 8.7E-09 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg08788930 | chr8:142201685 | DENND3 | 0.12 | 1E-08 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg10177197 | chr1:55316481 | DHCR24 | 0.12 | 1E-08 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg15650719 | chr16:50321812 | ADCY7 | 0.12 | 1.2E-08 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg22559900 | chr20:49125450 | PTPN1 | 0.12 | 1.2E-08 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg01101459 | chr1:234871477 | - | 0.087 | 1.4E-08 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg02154084 | chr5:146184364 | PPP2R2B | -0.11 | 1.7E-08 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg01695954 | chr2:10262019 | RRM2 | -0.085 | 2.1E-08 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg16470089 | chr16:87782144 | KLHDC4 | 0.092 | 2.2E-08 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg02907982 | chr12:131586900 | ADGRD1 | 0.12 | 2.3E-08 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg09823288 | chr1:239552128 | - | -0.051 | 2.8E-08 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg08352115 | chr17:66356057 | ARSG | 0.11 | 3.1E-08 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg15373972 | chr19:11219638 | LDLR | 0.1 | 3.2E-08 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg22679812 | chr16:70626213 | IL34 | 0.18 | 3.2E-08 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg13300580 | chr1:27440539 | SLC9A1 | 0.19 | 3.7E-08 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg19305903 | chr19:11203039 | LDLR | -0.1 | 3.7E-08 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg07167185 | chr1:24120017 | LYPLA2 | 0.095 | 3.8E-08 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg03068497 | chr7:30635838 | GARS | -0.054 | 4E-08 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg26457483 | chr1:120256112 | PHGDH | -0.074 | 4.2E-08 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg00508575 | chr12:90050967 | ATP2B1 | 0.12 | 4.4E-08 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg09018739 | chr16:57180107 | CPNE2 | 0.14 | 4.5E-08 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg19789753 | chr2:242805962 | - | -0.052 | 4.6E-08 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg21766592 | chr19:47288066 | SLC1A5 | -0.061 | 4.6E-08 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg24704287 | chr19:13951481 | - | -0.068 | 5.3E-08 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg03783904 | chr2:114588499 | - | 0.1 | 5.3E-08 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg19107904 | chr12:57541455 | LRP1-AS;LRP1 | 0.14 | 5.6E-08 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg09310636 | chr14:90760903 | NRDE2 | 0.12 | 5.6E-08 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg26236214 | chr13:111867078 | ARHGEF7 | 0.085 | 5.7E-08 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg03442477 | chr8:143746308 | JRK | 0.05 | 5.8E-08 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg05148610 | chr11:45954908 | PHF21A | 0.12 | 6E-08 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg16500036 | chr7:68983906 | - | 0.094 | 6.3E-08 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg26954174 | chr16:50730813 | NOD2 | -0.077 | 6.6E-08 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg26429850 | chr16:4464427 | CORO7-PAM16;CORO7 | 0.18 | 6.7E-08 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg05538032 | chr21:43681915 | ABCG1 | 0.11 | 6.8E-08 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg20958086 | chr1:160759689 | - | 0.13 | 7.6E-08 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg25407140 | chr2:201989737 | CFLAR | -0.076 | 8.3E-08 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg05399785 | chr1:3564031 | WDR8 | 0.076 | 9.1E-08 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg11089403 | chr1:153518867 | LOC101928034;S100A4 | -0.11 | 9.8E-08 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg17792970 | chr20:49125445 | PTPN1 | 0.13 | 1E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg02003183 | chr14:103415882 | CDC42BPB | 0.059 | 1.1E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg15989436 | chr5:150465875 | - | -0.091 | 1.1E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg16217672 | chr10:75843201 | VCL | 0.11 | 1.1E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg09737197 | chr11:68607675 | CPT1A | -0.067 | 1.1E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg07904865 | chr7:1127420 | GPER;C7orf50 | 0.085 | 1.2E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg00975876 | chr6:41752769 | PRICKLE4 | 0.14 | 1.2E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg03497652 | chr16:4751569 | ANKS3 | 0.081 | 1.3E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg16246545 | chr1:120255941 | PHGDH | -0.082 | 1.3E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg11254522 | chr1:27950343 | FGR | 0.14 | 1.3E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg13821176 | chr8:126448338 | TRIB1 | 0.1 | 1.3E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg20378147 | chr1:32050627 | TINAGL1 | 0.054 | 1.4E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg00826902 | chr1:3563954 | WDR8 | 0.068 | 1.5E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg01198738 | chr8:121597619 | SNTB1 | -0.074 | 1.5E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg03380960 | chr10:126325408 | FAM53B | 0.15 | 1.6E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg27338102 | chr9:107769113 | - | 0.096 | 1.6E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg08673945 | chr9:20490677 | MLLT3 | -0.093 | 1.6E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg19755576 | chr7:923089 | GET4 | 0.11 | 1.7E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg02711271 | chr5:150003303 | SYNPO | 0.17 | 1.8E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg00723041 | chr22:42304331 | - | -0.18 | 1.8E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg08549335 | chr7:30387954 | ZNRF2 | -0.065 | 1.9E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg18149207 | chr1:151805634 | RORC | 0.14 | 1.9E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg13707794 | chr21:35889668 | RCAN1 | -0.085 | 1.9E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg19751789 | chr19:11199944 | LDLR | -0.076 | 2E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg00285394 | chr8:126011954 | SQLE | -0.061 | 2E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg21506299 | chr6:137105225 | MAP3K5 | -0.076 | 2E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg05664974 | chr7:72915960 | BAZ1B | 0.15 | 2.1E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg12871401 | chr7:43915763 | URGCP;URGCP-MRPS24 | 0.11 | 2.1E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg26450266 | chr17:18149687 | FLII | 0.12 | 2.1E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg07504977 | chr10:102131012 | - | 0.076 | 2.3E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg18315935 | chr1:45120295 | TMEM53 | 0.066 | 2.5E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg11494773 | chr7:48128242 | UPP1 | -0.056 | 2.5E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg15557438 | chr2:219192031 | PNKD;CATIP-AS2 | -0.15 | 2.5E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg15985561 | chr2:221677163 | - | 0.056 | 2.5E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg02698507 | chr19:6091873 | RFX2 | 0.099 | 2.6E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg03743771 | chr12:108961135 | ISCU | 0.14 | 2.6E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg01875596 | chr18:22933696 | ZNF521 | -0.083 | 2.6E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg24115215 | chr17:38488052 | RARA | 0.14 | 2.6E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg00441899 | chr4:3432483 | RGS12 | 0.093 | 2.7E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg17820878 | chr1:27440463 | SLC9A1 | 0.078 | 2.7E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg02732789 | chr16:17491177 | XYLT1 | -0.094 | 2.7E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg27553457 | chr19:45899615 | PPP1R13L | 0.06 | 2.9E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg22538240 | chr1:118166138 | FAM46C | 0.091 | 2.9E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg10587886 | chr3:8361835 | LMCD1-AS1 | -0.058 | 2.9E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg09559780 | chr16:50727221 | - | -0.11 | 3.1E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg23606775 | chr1:9790616 | CLSTN1 | 0.15 | 3.1E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg16173675 | chr15:92652540 | SLCO3A1 | 0.11 | 3.1E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg13784312 | chr9:134609065 | RAPGEF1 | -0.058 | 3.2E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg21429551 | chr7:30635762 | GARS | -0.046 | 3.2E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg20493075 | chr17:80556724 | FOXK2 | 0.11 | 3.3E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg11847601 | chr16:57180054 | CPNE2 | 0.19 | 3.3E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg12013591 | chr19:11199965 | LDLR | -0.093 | 3.4E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg15370819 | chr19:54379397 | MYADM | 0.12 | 3.4E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg22839412 | chr15:31631841 | KLF13 | 0.11 | 3.6E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg18654932 | chr1:145433592 | NBPF20;NBPF10 | -0.1 | 3.6E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg03523676 | chr14:24540235 | CPNE6 | 0.11 | 3.6E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg15956680 | chr2:29195923 | - | 0.088 | 3.7E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg20131596 | chr5:102201128 | PAM | -0.12 | 3.7E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg10083914 | chr15:61372988 | RORA | -0.1 | 3.8E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg16097041 | chr1:154965544 | FLAD1;LENEP | 0.13 | 4.1E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg26228218 | chr5:147766754 | FBXO38 | 0.063 | 4.1E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg26889953 | chr15:22915992 | CYFIP1 | -0.14 | 4.5E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg18151437 | chr19:56638601 | - | 0.16 | 4.5E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg03725309 | chr1:109757585 | SARS | -0.074 | 4.6E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg03078690 | chr6:33235504 | VPS52 | 0.13 | 4.7E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg05783906 | chr10:129901421 | MKI67 | 0.068 | 4.9E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg24507742 | chr19:47288244 | SLC1A5 | -0.068 | 5.1E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg21929761 | chr1:32250675 | - | 0.13 | 5.2E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg27152890 | chr19:45900241 | PPP1R13L | 0.033 | 5.5E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg26665444 | chr15:63791209 | - | -0.059 | 5.5E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg17188688 | chr22:22333247 | TOP3B | 0.079 | 5.7E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg27037013 | chr21:35320667 | - | -0.064 | 5.8E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg01538969 | chr6:30624636 | DHX16 | 0.11 | 6E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg06285727 | chr11:72524028 | ATG16L2 | -0.071 | 6E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg07640662 | chr4:141721849 | - | 0.086 | 6E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg18787963 | chr17:76409193 | PGS1 | -0.12 | 6.1E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg04937481 | chr20:5637035 | - | 0.1 | 6.4E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg17814814 | chr1:222060676 | - | 0.13 | 6.5E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg26063719 | chr10:17273187 | VIM | -0.067 | 6.6E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg11921829 | chr1:157746930 | FCRL2 | -0.078 | 6.7E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg22061529 | chr8:133689378 | - | 0.081 | 6.8E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg07486119 | chr7:2596723 | BRAT1 | 0.094 | 6.9E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg06211750 | chr10:99528507 | SFRP5 | 0.11 | 7.3E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg24254409 | chr19:14618044 | - | 0.12 | 7.4E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg00021659 | chr2:161996385 | TANK | -0.07 | 7.7E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg26880882 | chr17:76822808 | USP36 | 0.069 | 8.1E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg11253416 | chr8:82643680 | CHMP4C | -0.064 | 8.1E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg24929954 | chr5:14400864 | TRIO | 0.085 | 8.4E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg07023764 | chr8:130567184 | CCDC26 | 0.065 | 8.4E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg17586156 | chr19:42931757 | LIPE;LIPE-AS1 | 0.088 | 8.4E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg08362785 | chr22:40814878 | MKL1 | 0.11 | 8.5E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg16824319 | chr1:248903933 | LOC646627 | 0.12 | 8.5E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg26160945 | chr12:27396706 | STK38L | 0.084 | 8.5E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg07384001 | chr14:52779847 | PTGER2 | -0.089 | 8.6E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg00353899 | chr18:59999037 | TNFRSF11A | 0.12 | 8.7E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg23756264 | chr11:68605511 | CPT1A | -0.12 | 8.9E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg14827056 | chr8:141550539 | EIF2C2 | 0.1 | 9E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg19027130 | chr22:42242382 | SREBF2 | -0.092 | 9.1E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg16815625 | chr8:141229477 | TRAPPC9 | 0.059 | 9.5E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg15818948 | chr20:19638681 | SLC24A3 | -0.078 | 9.9E-07 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg21252105 | chr9:139459307 | - | -0.12 | 1E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg02976843 | chr17:2843257 | RAP1GAP2 | 0.12 | 1E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg19572574 | chr10:63592731 | - | -0.086 | 1.1E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg08857797 | chr17:40927699 | VPS25 | 0.09 | 1.1E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg23002247 | chr17:79894684 | PYCR1 | -0.094 | 1.1E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg27061485 | chr16:88989387 | CBFA2T3 | -0.13 | 1.1E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg26804423 | chr7:8201134 | ICA1 | 0.11 | 1.1E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg14750543 | chr20:4776111 | RASSF2 | 0.083 | 1.2E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg10636246 | chr1:159046973 | AIM2 | -0.047 | 1.2E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg23931381 | chr19:18119847 | ARRDC2 | -0.055 | 1.3E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg18581998 | chr9:136335884 | CACFD1 | 0.058 | 1.3E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg22654422 | chr3:196365939 | NRROS | -0.083 | 1.3E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg05473729 | chr1:216978426 | ESRRG | -0.07 | 1.3E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg08316365 | chr12:102512153 | NUP37 | 0.07 | 1.3E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg23204398 | chr8:126365081 | NSMCE2 | 0.066 | 1.3E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg16892812 | chr7:121796366 | - | -0.14 | 1.3E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg01153902 | chr19:19713903 | PBX4 | -0.091 | 1.3E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg12666727 | chr1:42128487 | HIVEP3 | -0.054 | 1.4E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg09993145 | chr1:25291905 | RUNX3 | 0.077 | 1.4E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg13034073 | chr7:2769681 | GNA12 | 0.1 | 1.4E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg00851028 | chr1:234905772 | - | 0.11 | 1.4E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg00683922 | chr1:207242569 | PFKFB2 | 0.076 | 1.4E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg26416615 | chr10:63751843 | ARID5B | -0.072 | 1.4E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg04159877 | chr11:64568069 | MAP4K2 | -0.14 | 1.4E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg15302942 | chr12:6740462 | LPAR5 | 0.15 | 1.4E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg08170375 | chr3:50247180 | SLC38A3 | -0.11 | 1.4E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg14105458 | chr9:139917436 | ABCA2 | 0.056 | 1.5E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg12888432 | chr17:66315002 | ARSG | -0.11 | 1.5E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg11129609 | chr6:33247250 | WDR46 | 0.14 | 1.5E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg23008745 | chr12:132070697 | - | 0.062 | 1.5E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg18755830 | chr14:24988245 | - | 0.047 | 1.5E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg03173169 | chr2:75060921 | HK2 | 0.065 | 1.6E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg07343629 | chr15:75280562 | - | 0.078 | 1.6E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg11202345 | chr17:76976057 | LGALS3BP | 0.062 | 1.6E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg23072383 | chr22:31031044 | SLC35E4 | -0.056 | 1.6E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg00163198 | chr11:130767760 | SNX19 | 0.091 | 1.7E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg09741846 | chr10:75413775 | SYNPO2L | 0.14 | 1.7E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg16374343 | chr17:1014352 | ABR | -0.15 | 1.7E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg09245003 | chr17:695428 | RNMTL1 | 0.092 | 1.8E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg03525643 | chr2:145915743 | - | -0.089 | 1.8E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg21421012 | chr9:138797992 | CAMSAP1 | 0.074 | 1.8E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg12319836 | chr19:1090235 | POLR2E | 0.13 | 1.8E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg00730203 | chr12:86907706 | MGAT4C | 0.058 | 1.8E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg08554257 | chr16:50730737 | NOD2 | -0.059 | 1.9E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg24782497 | chr19:18385409 | KIAA1683 | 0.16 | 1.9E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg18217136 | chr20:36157651 | BLCAP | 0.11 | 1.9E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg20891006 | chr17:43833867 | MGC57346-CRHR1 | 0.066 | 2E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg10474793 | chr6:16134001 | MYLIP | 0.082 | 2E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg25653947 | chr8:144443217 | - | 0.12 | 2E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg14487183 | chr19:42644307 | - | 0.1 | 2.1E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg19377661 | chr3:142605811 | PCOLCE2 | -0.055 | 2.1E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg05721285 | chr22:36844807 | - | 0.12 | 2.1E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg12543096 | chr21:43722429 | - | 0.09 | 2.1E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg20507228 | chr15:91460071 | MAN2A2 | 0.07 | 2.1E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg02787218 | chr3:48717275 | NCKIPSD | 0.16 | 2.2E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg04181189 | chr11:129817418 | PRDM10 | 0.13 | 2.2E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg11271054 | chr2:101270289 | - | 0.093 | 2.2E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg20366862 | chr3:47098794 | SETD2 | 0.11 | 2.2E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg18062721 | chr3:11643427 | VGLL4 | 0.065 | 2.3E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg01470900 | chr19:39369830 | RINL;SIRT2 | 0.13 | 2.3E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg25618457 | chr2:219187295 | PNKD | -0.15 | 2.3E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg11504495 | chr7:48128148 | UPP1 | -0.057 | 2.4E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg14194410 | chr3:119500686 | NR1I2 | 0.085 | 2.4E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg16618104 | chr12:104853100 | CHST11 | -0.063 | 2.5E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg09777883 | chr11:112093696 | - | 0.099 | 2.5E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg17237086 | chr22:40814966 | MKL1 | 0.14 | 2.5E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg07971007 | chr17:79127372 | AATK | 0.091 | 2.6E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg23804054 | chr2:201980467 | CFLAR | -0.044 | 2.7E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg04286697 | chr2:232259623 | B3GNT7 | 0.1 | 2.7E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg09959532 | chr3:186145519 | - | 0.13 | 2.7E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg24540279 | chr10:63701252 | ARID5B | -0.064 | 2.7E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg12968684 | chr5:158246281 | EBF1 | -0.074 | 2.7E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg24843003 | chr19:1409547 | DAZAP1 | 0.12 | 2.7E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg04379002 | chr16:89004334 | CBFA2T3 | -0.13 | 2.8E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg03997105 | chr16:54404570 | - | -0.055 | 2.8E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg15922057 | chr17:25784714 | - | -0.082 | 2.8E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg12744591 | chr22:39864408 | MGAT3 | 0.15 | 2.9E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg10926420 | chr2:69852289 | AAK1 | -0.11 | 3E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg05144113 | chr12:56578049 | SMARCC2 | 0.081 | 3E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg14177325 | chr17:1541763 | SCARF1 | 0.094 | 3E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg03169557 | chr16:89598950 | SPG7 | 0.048 | 3.1E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg11746531 | chr17:25784992 | - | -0.11 | 3.1E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg01162438 | chr16:48952486 | - | -0.071 | 3.1E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg22998476 | chr10:74058092 | - | -0.082 | 3.1E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg22699725 | chr1:207242586 | PFKFB2 | 0.074 | 3.1E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg04608193 | chr2:28618016 | FLJ31356;FOSL2 | -0.081 | 3.1E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg07078732 | chr2:30505165 | - | 0.15 | 3.2E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg14222701 | chr11:46564725 | AMBRA1 | 0.096 | 3.2E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg05624954 | chr5:179340170 | - | 0.061 | 3.3E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg17951990 | chr12:50435516 | - | 0.086 | 3.3E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg03609661 | chr17:4513314 | - | -0.092 | 3.3E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg24590766 | chr1:45436367 | EIF2B3 | -0.089 | 3.3E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg00526281 | chr11:48101308 | PTPRJ | 0.096 | 3.5E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg07184639 | chr2:23570056 | - | -0.11 | 3.5E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg08949269 | chr20:31443298 | - | 0.096 | 3.5E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg26225774 | chr3:128690750 | KIAA1257 | 0.06 | 3.6E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg16272728 | chr15:55569254 | RAB27A | -0.064 | 3.6E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg13975599 | chr14:90974270 | - | -0.12 | 3.6E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg17750024 | chr1:175538621 | TNR | -0.069 | 3.6E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg25390749 | chr16:87781404 | KLHDC4 | 0.086 | 3.6E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg04927537 | chr17:76976091 | LGALS3BP | 0.061 | 3.7E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg15082870 | chr7:36022841 | - | 0.095 | 3.7E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg13032736 | chr14:50506638 | LINC01599 | -0.071 | 3.8E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg11832534 | chr1:3563998 | WDR8 | 0.059 | 3.8E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg14870271 | chr17:76976010 | LGALS3BP | 0.084 | 3.8E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg06071604 | chr13:100069110 | - | 0.11 | 3.8E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg04907244 | chr7:22894795 | SNORD93 | -0.046 | 3.8E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg06088069 | chr14:75895604 | JDP2 | -0.12 | 3.8E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg04381163 | chr22:31852077 | EIF4ENIF1 | 0.091 | 3.8E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg04987734 | chr14:103415873 | CDC42BPB | 0.073 | 3.9E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg05021589 | chr6:6588931 | LY86;LOC285780 | 0.086 | 3.9E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg08315613 | chr19:11074303 | SMARCA4 | 0.16 | 3.9E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg20376277 | chr5:16615924 | LOC101929524;FAM134B | 0.059 | 4E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg15170740 | chr12:129302461 | SLC15A4 | -0.066 | 4E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg01223011 | chr3:128714144 | KIAA1257 | 0.11 | 4.1E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg16504526 | chr9:73025362 | KLF9 | 0.069 | 4.1E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg27630863 | chr18:45428160 | SMAD2 | 0.068 | 4.2E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg15296347 | chr19:46319493 | RSPH6A;SYMPK | -0.15 | 4.2E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg09816821 | chr16:88709302 | - | 0.089 | 4.3E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg12712122 | chr6:88435312 | - | 0.062 | 4.3E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg04326337 | chr20:36664969 | RPRD1B | 0.078 | 4.3E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg03776506 | chr16:30581384 | ZNF688 | 0.077 | 4.4E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg12687886 | chr3:14200205 | XPC | 0.074 | 4.4E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg26841040 | chr1:228332263 | GUK1 | 0.15 | 4.4E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg24726852 | chr1:78313327 | FAM73A | 0.065 | 4.4E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg03963219 | chr2:84709147 | - | 0.072 | 4.4E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg00202345 | chr10:77503513 | C10orf11 | -0.1 | 4.4E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg12307174 | chr14:68555650 | RAD51B | -0.049 | 4.4E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg26176001 | chr16:86017380 | - | -0.13 | 4.4E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg10761804 | chr19:1865012 | KLF16 | -0.072 | 4.5E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg10297007 | chr6:16699991 | ATXN1 | -0.053 | 4.5E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg15183129 | chr1:160759781 | - | 0.1 | 4.5E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg07402801 | chr1:20756675 | LINC01141 | -0.084 | 4.5E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg22304262 | chr19:47287778 | SLC1A5 | -0.073 | 4.5E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg03498995 | chr20:30656899 | HCK | -0.079 | 4.7E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg25416818 | chr1:91189508 | - | 0.063 | 4.7E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg05963604 | chr3:57263543 | APPL1 | -0.072 | 4.8E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg00784329 | chr2:122530032 | - | 0.073 | 4.8E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg27305772 | chr11:65630355 | MUS81 | 0.11 | 4.9E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg15144123 | chr3:47655398 | SMARCC1 | 0.13 | 5E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg18568872 | chr15:90606494 | ZNF710 | 0.15 | 5.1E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg12378285 | chr2:136808729 | - | 0.078 | 5.1E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg15037126 | chr15:75221364 | COX5A | 0.092 | 5.1E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg25285289 | chr2:96899771 | STARD7-AS1 | 0.11 | 5.2E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg01265971 | chr3:156398928 | TIPARP | -0.075 | 5.2E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg04273431 | chr6:30523215 | GNL1;PRR3 | -0.086 | 5.2E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg27254641 | chr1:150265869 | MRPS21 | -0.1 | 5.2E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg26465469 | chr7:922981 | GET4 | 0.11 | 5.2E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg23990942 | chr19:40946878 | SERTAD3 | -0.14 | 5.2E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg18933133 | chr8:38705090 | TACC1 | 0.093 | 5.3E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg26034658 | chr11:65836743 | PACS1 | 0.13 | 5.3E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg26546155 | chr16:57269635 | RSPRY1 | 0.11 | 5.4E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg24935121 | chr1:155022635 | ADAM15;DCST1 | -0.082 | 5.4E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg01176028 | chr21:43653234 | ABCG1 | 0.08 | 5.4E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg23299102 | chr7:36495922 | - | 0.084 | 5.4E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg27470213 | chr17:76967695 | LGALS3BP | -0.051 | 5.6E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg08778768 | chr15:70052769 | - | -0.068 | 5.6E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg06625767 | chr5:176836695 | F12 | -0.1 | 5.6E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg25244908 | chr14:75680221 | - | 0.12 | 5.6E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg26849535 | chr19:11199222 | LDLR | -0.076 | 5.6E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg20671781 | chr10:43626471 | - | 0.093 | 5.7E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg01379386 | chr21:30517714 | MAP3K7CL | -0.059 | 5.7E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg22598557 | chr16:21049838 | DNAH3 | 0.091 | 5.7E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg06036471 | chr10:93861385 | CPEB3 | 0.064 | 5.8E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg24686420 | chr8:48540511 | SPIDR | 0.061 | 5.8E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg23876991 | chr16:87781498 | KLHDC4 | 0.071 | 5.8E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg02385309 | chr22:38609371 | MAFF | 0.085 | 5.8E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg16457614 | chr10:43539598 | - | 0.11 | 5.8E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg17408993 | chr12:65110360 | GNS | 0.071 | 5.9E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg18894545 | chr4:42281051 | - | 0.062 | 5.9E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg19202384 | chr17:79894511 | PYCR1 | -0.089 | 6E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg16371518 | chr11:46564493 | AMBRA1 | 0.094 | 6E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg13733787 | chr8:141229379 | TRAPPC9 | 0.054 | 6E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg21806810 | chr5:34978951 | - | -0.047 | 6E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg05321694 | chr10:72344731 | - | -0.11 | 6.2E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg14791398 | chr3:18462444 | SATB1 | 0.072 | 6.2E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg27516100 | chr6:30624520 | DHX16 | 0.11 | 6.2E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg08276042 | chr16:2740348 | KCTD5 | -0.11 | 6.3E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg00757950 | chr8:66791763 | - | 0.072 | 6.3E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg23750151 | chr6:32808504 | PSMB8 | 0.048 | 6.4E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg17969042 | chr11:64643263 | EHD1 | -0.098 | 6.7E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg16851743 | chr17:79416550 | BAHCC1 | 0.084 | 6.7E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg00448560 | chr16:49525727 | ZNF423 | -0.088 | 6.8E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg22895366 | chr22:39574449 | - | -0.058 | 6.9E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg00210939 | chr17:79546777 | NPLOC4 | 0.1 | 7E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg04953230 | chr11:65273641 | MALAT1 | 0.065 | 7E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg26663590 | chr16:28959310 | - | 0.086 | 7E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg13091627 | chr1:153518476 | S100A4 | -0.066 | 7E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg02091428 | chr16:71662998 | MARVELD3 | 0.1 | 7.3E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg02744945 | chr13:32738953 | FRY | 0.098 | 7.3E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg16743323 | chr2:60758083 | BCL11A | -0.12 | 7.3E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg25178683 | chr17:76976267 | LGALS3BP | 0.083 | 7.3E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg18668685 | chr20:48411590 | - | -0.078 | 7.3E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg21494379 | chr5:88275243 | - | -0.062 | 7.4E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg06385226 | chr20:62539841 | DNAJC5 | 0.069 | 7.4E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg24619988 | chr12:95193112 | - | 0.063 | 7.5E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg24555528 | chr12:50046087 | FMNL3 | 0.15 | 7.5E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg24912334 | chr15:77473379 | PEAK1 | 0.074 | 7.5E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg23000734 | chr10:126850823 | CTBP2 | -0.029 | 7.6E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg21131989 | chr1:88319865 | - | -0.082 | 7.7E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg02067535 | chr3:196366191 | LRRC33 | -0.057 | 7.7E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg21281638 | chr7:6631355 | C7orf26 | 0.064 | 7.7E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg11410920 | chr20:43997025 | SYS1;SYS1-DBNDD2 | 0.062 | 7.8E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg21196487 | chr1:153538964 | S100A2 | -0.079 | 7.8E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg01699600 | chr16:88844726 | FAM38A | -0.084 | 7.9E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg12767903 | chr3:114027886 | TIGIT | -0.072 | 7.9E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg07750834 | chr15:71040854 | UACA | 0.062 | 7.9E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg02192976 | chr9:124119569 | STOM | -0.071 | 8E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg26556529 | chr1:41308035 | - | -0.087 | 8.1E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg02841912 | chr6:152955983 | SYNE1 | -0.062 | 8.2E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg04323387 | chr14:50506635 | LINC01599 | -0.11 | 8.3E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg18585107 | chr11:64138839 | RPS6KA4 | 0.055 | 8.3E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg06178887 | chr19:42599631 | POU2F2 | 0.12 | 8.3E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg27101967 | chr9:107527578 | NIPSNAP3B | 0.066 | 8.3E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg19092476 | chr4:152973683 | - | -0.075 | 8.3E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg09988805 | chr2:43278552 | - | 0.081 | 8.3E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg23325335 | chr15:99979290 | - | 0.06 | 8.4E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg06048090 | chr16:14653752 | PARN | 0.079 | 8.4E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg25963583 | chr14:65539104 | MAX | 0.063 | 8.5E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg05843106 | chr4:186030462 | - | -0.12 | 8.5E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg17448641 | chr7:110830832 | IMMP2L | -0.068 | 8.5E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg01140719 | chr4:40616224 | RBM47 | 0.15 | 8.7E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg05941925 | chr7:97755783 | LMTK2 | 0.088 | 8.7E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg05141280 | chr1:110078630 | - | 0.073 | 8.8E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg25503259 | chr17:29731206 | RAB11FIP4 | 0.089 | 8.8E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg16677191 | chr5:95159423 | GLRX | -0.066 | 8.8E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg01044314 | chr19:2442930 | LMNB2 | 0.079 | 8.8E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg15059254 | chr16:17555963 | XYLT1 | -0.095 | 9E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg19402463 | chr9:132872679 | GPR107 | 0.099 | 9E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg05692532 | chr19:49136928 | DBP | 0.11 | 9.1E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg03124880 | chr12:108617533 | WSCD2 | 0.057 | 9.1E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg01000627 | chr11:48023430 | PTPRJ | 0.066 | 9.1E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg10040669 | chr8:9010317 | PPP1R3B | -0.11 | 9.2E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg17660183 | chr12:105065386 | CHST11 | -0.054 | 9.3E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg16295975 | chr1:154405251 | IL6R | -0.086 | 9.4E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg27445698 | chr1:35315676 | - | 0.063 | 9.4E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg03883939 | chr3:49754876 | AMIGO3;RNF123 | 0.1 | 9.4E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg12703549 | chr2:85821807 | RNF181 | 0.087 | 9.5E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg22898082 | chr19:11074428 | SMARCA4 | 0.14 | 9.5E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg19799762 | chr2:102755019 | IL1R1 | -0.069 | 9.8E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg22407942 | chr7:22894828 | SNORD93 | -0.046 | 9.8E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg03366574 | chr7:2764599 | - | 0.047 | 9.9E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg11952344 | chr17:80398854 | HEXDC | 0.1 | 9.9E-06 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg15971496 | chr17:695156 | RNMTL1 | 0.055 | 1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg03952533 | chr21:43679795 | ABCG1 | 0.13 | 1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg14564724 | chr9:107687761 | ABCA1 | 0.079 | 1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg03062284 | chr2:122994061 | - | -0.1 | 1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg15964779 | chr19:55709086 | PTPRH | -0.075 | 1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg23724135 | chr6:149641504 | TAB2 | -0.051 | 1.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg18758281 | chr2:161808953 | - | 0.071 | 1.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg14297410 | chr2:63351486 | WDPCP | -0.056 | 1.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg10802680 | chr12:122712075 | DIABLO | 0.13 | 1.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg19741548 | chr8:74963339 | - | 0.09 | 1.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg24374476 | chr10:74080727 | - | -0.084 | 1.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg23732483 | chr3:48965611 | ARIH2 | -0.064 | 1.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg16060330 | chr2:173369204 | ITGA6 | 0.048 | 1.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg04169527 | chr11:9759805 | SWAP70 | 0.088 | 1.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg09185640 | chr15:68875671 | CORO2B | 0.15 | 1.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg23580000 | chr16:50322156 | ADCY7 | 0.094 | 1.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg11997486 | chr6:14100671 | - | 0.12 | 1.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg02068690 | chr2:25600451 | DTNB | 0.13 | 1.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg25228947 | chr22:43082543 | - | 0.17 | 1.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg19391380 | chr8:97939240 | CPQ | 0.1 | 1.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg23329156 | chr3:190231815 | IL1RAP | 0.073 | 1.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg24774517 | chr6:42742564 | - | -0.065 | 1.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg19679801 | chr5:145422431 | SH3RF2 | -0.061 | 1.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg17411016 | chr2:47100912 | - | -0.13 | 1.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg05089897 | chr21:38886664 | DYRK1A | 0.079 | 1.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg02961101 | chr16:48533155 | - | -0.072 | 1.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg16563370 | chr17:33775952 | SLFN13 | -0.12 | 1.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg08740365 | chr2:232385118 | - | -0.12 | 1.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg02448796 | chr1:6101339 | KCNAB2 | 0.068 | 1.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg06721411 | chr2:74753759 | DQX1 | 0.11 | 1.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg12231373 | chr6:36628103 | - | 0.03 | 1.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg18419125 | chr5:162866149 | CCNG1 | -0.062 | 1.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg00025991 | chr10:736625 | DIP2C | 0.1 | 1.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg04365911 | chr1:207536634 | - | 0.084 | 1.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg24465561 | chr3:57082976 | ARHGEF3 | 0.057 | 1.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg15375526 | chr3:141989359 | - | -0.073 | 1.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg05660634 | chr15:38965109 | - | 0.056 | 1.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg01273012 | chr18:6257974 | L3MBTL4-AS1;L3MBTL4 | -0.11 | 1.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg11525951 | chr21:43641170 | ABCG1 | 0.072 | 1.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg24054032 | chr1:68118899 | - | 0.098 | 1.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg21054077 | chr17:75924573 | - | 0.081 | 1.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg07925587 | chr12:52583324 | KRT80 | -0.066 | 1.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg08472633 | chr16:88907370 | GALNS | -0.13 | 1.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg22530144 | chr2:46300869 | PRKCE | -0.07 | 1.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg09888648 | chr8:143456215 | TSNARE1 | 0.064 | 1.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg00410753 | chr16:68033859 | DPEP2 | 0.13 | 1.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg03328982 | chr14:24910296 | KHNYN;SDR39U1 | 0.079 | 1.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg12033822 | chr20:44990591 | SLC35C2 | -0.11 | 1.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg24129923 | chr17:7814251 | CHD3 | 0.083 | 1.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg02879453 | chr16:50321818 | ADCY7 | 0.074 | 1.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg10755899 | chr4:1772151 | - | 0.043 | 1.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg24569251 | chr6:36628087 | - | 0.033 | 1.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg24004483 | chr1:944783 | - | -0.061 | 1.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg08779252 | chr12:124875481 | NCOR2 | -0.12 | 1.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg06743610 | chr19:35630305 | FXYD1 | -0.083 | 1.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg27042693 | chr11:26492697 | ANO3 | 0.043 | 1.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg24850296 | chr12:25707569 | IFLTD1 | -0.076 | 1.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg08110950 | chr13:49109917 | - | 0.1 | 1.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg02650017 | chr17:47301614 | PHOSPHO1 | -0.055 | 1.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg24986815 | chr1:227128974 | ADCK3 | -0.12 | 1.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg22798948 | chr3:65066311 | - | 0.089 | 1.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg00685038 | chr9:133970508 | AIF1L | 0.12 | 1.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg24568579 | chr12:111841024 | - | -0.084 | 1.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg16679543 | chr6:157913024 | ZDHHC14 | 0.046 | 1.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg00034336 | chr2:8684126 | - | -0.056 | 1.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg23925513 | chr17:6923526 | - | -0.089 | 1.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg07021906 | chr16:87866833 | SLC7A5 | 0.073 | 1.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg22700686 | chr1:153538764 | S100A2 | -0.064 | 1.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg00309945 | chr1:22148926 | LDLRAD2;HSPG2 | 0.077 | 1.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg25024312 | chr16:48653541 | MIR5095 | 0.12 | 1.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg22417925 | chr8:144443010 | TOP1MT | 0.083 | 1.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg16526705 | chr19:17284481 | MYO9B | 0.099 | 1.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg09019636 | chr2:62964766 | EHBP1 | -0.089 | 1.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg05971010 | chr16:816650 | MSLN | -0.076 | 1.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg11909142 | chr20:18491545 | SEC23B | -0.12 | 1.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg04973802 | chr16:6696189 | A2BP1 | -0.065 | 1.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg08305942 | chr16:79692354 | - | -0.086 | 1.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg09147065 | chr8:143815906 | C8orf55 | 0.069 | 1.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg13098353 | chr8:27497369 | SCARA3 | 0.063 | 1.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg26559804 | chr11:128391271 | ETS1 | -0.044 | 1.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg20793665 | chr2:232549224 | - | 0.063 | 1.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg17031048 | chr16:75036150 | ZNRF1 | -0.056 | 1.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg15713169 | chr20:3297193 | C20orf194 | 0.051 | 1.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg13854193 | chr11:116723395 | APOA1-AS;SIK3 | -0.066 | 1.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg14559224 | chr17:73841195 | UNC13D | -0.14 | 1.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg04406204 | chr4:38530952 | - | -0.11 | 1.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg12130407 | chr22:30942894 | SEC14L6 | 0.075 | 1.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg12159583 | chr9:134532611 | RAPGEF1 | 0.059 | 1.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg19708903 | chr10:133784308 | BNIP3 | 0.1 | 1.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg17749033 | chr17:80197412 | - | -0.13 | 1.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg17753124 | chr19:13259872 | IER2;STX10 | -0.12 | 1.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg11951600 | chr2:178417568 | TTC30B | 0.071 | 1.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg03070999 | chr12:6745630 | LPAR5 | 0.13 | 1.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg14847622 | chr22:28106439 | - | 0.071 | 1.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg04893758 | chr1:153722267 | INTS3 | 0.066 | 1.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg19719320 | chr3:183118470 | MCF2L2 | 0.11 | 1.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg26732808 | chr6:167704769 | UNC93A | -0.066 | 1.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg11629830 | chr5:75701460 | IQGAP2 | -0.059 | 1.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg07138962 | chr14:100035588 | CCDC85C | 0.081 | 1.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg10342963 | chr15:99443213 | IGF1R | 0.055 | 1.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg07719512 | chr2:219246576 | SLC11A1 | 0.15 | 1.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg09868035 | chr20:62492074 | C20orf135 | -0.11 | 1.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg15428169 | chr11:60749794 | CD6 | 0.11 | 1.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg27182880 | chr5:16623360 | LOC101929524 | 0.084 | 1.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg11201264 | chr11:62520685 | ZBTB3 | -0.1 | 1.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg18189915 | chr11:3050521 | CARS | 0.1 | 1.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg06122773 | chr12:131842648 | LOC338797 | 0.062 | 1.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg25153505 | chr2:134322791 | NCKAP5 | -0.094 | 1.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg01287377 | chr3:60064969 | FHIT | 0.07 | 1.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg16569525 | chr20:55402743 | - | -0.042 | 1.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg21327712 | chr1:111744503 | DENND2D | 0.068 | 1.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg11860071 | chr5:135254112 | - | -0.091 | 1.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg02711608 | chr19:47287964 | SLC1A5 | -0.059 | 1.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg26955383 | chr10:105218660 | CALHM1 | 0.062 | 1.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg16595918 | chr17:7120162 | ACADVL;DLG4 | -0.13 | 1.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg09978270 | chr1:236732064 | HEATR1 | 0.055 | 1.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg11772799 | chr7:158799715 | LOC154822 | -0.048 | 1.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg13518625 | chr8:29522838 | - | -0.047 | 1.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg08425610 | chr19:46029456 | VASP | 0.12 | 1.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg17475467 | chr1:55316769 | DHCR24 | 0.093 | 1.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg16284674 | chr10:135123337 | ZNF511;TUBGCP2 | 0.049 | 1.8E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg17552056 | chr14:22981619 | - | 0.059 | 1.8E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg02694058 | chr8:19540254 | CSGALNACT1 | -0.047 | 1.8E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg15841205 | chr14:37056458 | - | 0.042 | 1.8E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg05183753 | chr1:239553133 | - | -0.074 | 1.8E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg09008531 | chr16:46695850 | VPS35 | 0.08 | 1.8E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg18394552 | chr5:159428643 | - | 0.068 | 1.8E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg22761431 | chr17:7609416 | EFNB3 | 0.058 | 1.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg25365807 | chr16:67168621 | C16orf70 | 0.066 | 1.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg23680451 | chr10:3823790 | KLF6 | -0.06 | 1.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg12992827 | chr3:101901234 | - | -0.059 | 1.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg02628581 | chr6:149641011 | TAB2 | -0.055 | 1.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg25922180 | chr4:693321 | - | -0.052 | 1.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg27377114 | chr11:87133817 | - | -0.11 | 1.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg17666418 | chr6:106612002 | - | -0.054 | 1.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg23190089 | chr11:2920209 | SLC22A18AS;SLC22A18 | -0.06 | 1.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg13843006 | chr20:10770832 | - | -0.12 | 1.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg26269881 | chr3:5023310 | BHLHE40 | -0.059 | 1.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg00370047 | chr11:1481436 | BRSK2 | 0.07 | 2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg17019377 | chr15:91417710 | FURIN | -0.12 | 2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg02305358 | chr17:75930111 | - | 0.066 | 2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg16514888 | chr20:48293214 | B4GALT5 | -0.064 | 2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg07284463 | chr14:54917898 | - | 0.083 | 2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg22312060 | chr10:22311832 | - | 0.066 | 2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg19883525 | chr2:71419021 | PAIP2B | 0.098 | 2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg12013661 | chr5:32446941 | - | 0.11 | 2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg25114611 | chr6:35696870 | FKBP5;LOC285847 | -0.075 | 2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg07858756 | chr17:9273972 | STX8 | -0.11 | 2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg21148428 | chr20:47487052 | - | -0.093 | 2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg01877778 | chr7:157415538 | PTPRN2 | 0.045 | 2.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg17198304 | chr1:116183849 | VANGL1 | -0.07 | 2.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg17573933 | chr17:46623780 | HOXB2 | -0.15 | 2.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg10107138 | chr17:77428823 | RBFOX3 | -0.058 | 2.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg27588321 | chr16:50775288 | CYLD | -0.076 | 2.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg24647919 | chr1:28439864 | - | 0.052 | 2.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg13587823 | chr2:158039725 | - | -0.072 | 2.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg07558761 | chr16:87866696 | SLC7A5 | 0.093 | 2.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg07641040 | chr22:40255881 | ENTHD1 | 0.066 | 2.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg15338665 | chr14:81916796 | LOC100506700 | 0.13 | 2.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg24263283 | chr15:59587546 | MYO1E | -0.062 | 2.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg00420997 | chr8:29607076 | C8orf75 | -0.062 | 2.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg25758699 | chr3:186257301 | CRYGS | 0.067 | 2.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg23761815 | chr10:73083123 | SLC29A3 | 0.092 | 2.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg11837076 | chr1:1711588 | NADK | -0.06 | 2.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg21444731 | chr22:24034126 | RGL4;LOC91316 | 0.11 | 2.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg07069844 | chr19:1617027 | TCF3 | 0.072 | 2.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg24773560 | chr12:56732723 | IL23A | 0.067 | 2.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg16655795 | chr19:42897238 | - | 0.1 | 2.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg03288347 | chr9:92163306 | - | 0.067 | 2.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg02086839 | chr8:144403439 | TOP1MT | 0.079 | 2.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg24798898 | chr3:184037523 | EIF4G1 | 0.098 | 2.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg23639734 | chr4:24796753 | SOD3 | 0.1 | 2.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg24556382 | chr4:174173455 | GALNT7 | -0.052 | 2.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg01602730 | chr1:153671011 | - | -0.063 | 2.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg26551200 | chr7:2681369 | TTYH3 | -0.12 | 2.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg08435683 | chr20:4836338 | SLC23A2 | 0.058 | 2.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg19216788 | chr3:121633802 | SLC15A2 | 0.063 | 2.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg09940677 | chr14:103415458 | CDC42BPB | 0.12 | 2.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg07072176 | chr8:140906190 | TRAPPC9 | 0.08 | 2.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg08809526 | chr14:100027909 | CCDC85C | 0.076 | 2.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg26253134 | chr2:70751721 | TGFA | -0.075 | 2.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg20073681 | chr16:4674013 | MGRN1 | 0.094 | 2.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg03222540 | chr15:90575080 | ZNF710 | 0.12 | 2.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg00134210 | chr10:14644132 | FAM107B | -0.05 | 2.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg26167736 | chr16:2568945 | ATP6V0C;AMDHD2 | 0.1 | 2.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg12644285 | chr15:93570953 | CHD2 | -0.067 | 2.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg16859755 | chr16:66770061 | DYNC1LI2 | 0.13 | 2.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg24304210 | chr11:77118761 | PAK1 | -0.076 | 2.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg08794720 | chr9:35538922 | RUSC2 | 0.087 | 2.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg00640087 | chr6:31707202 | MSH5 | -0.07 | 2.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg20455854 | chr5:139040849 | CXXC5 | -0.085 | 2.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg17992670 | chr19:11216306 | LDLR | 0.098 | 2.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg23608915 | chr2:102333795 | MAP4K4 | 0.055 | 2.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg23619829 | chr8:66556444 | MTFR1 | -0.04 | 2.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg14400946 | chr2:25805233 | DTNB | 0.083 | 2.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg24829842 | chr22:34139998 | LARGE-AS1;LARGE | -0.089 | 2.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg11948198 | chr19:45093792 | - | 0.076 | 2.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg16805291 | chr7:36022575 | - | 0.08 | 2.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg20740903 | chr17:76170799 | TK1 | -0.11 | 2.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg04177251 | chr4:8193123 | - | -0.097 | 2.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg01212167 | chr20:8286191 | PLCB1 | 0.064 | 2.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg12350057 | chr14:23768690 | PPP1R3E | 0.084 | 2.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg07276367 | chr10:6188415 | PFKFB3 | -0.1 | 2.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg23323108 | chr11:64643272 | EHD1 | -0.076 | 2.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg25607249 | chr19:47288039 | SLC1A5 | -0.053 | 2.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg26667287 | chr22:46419365 | - | 0.13 | 2.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg26974013 | chr19:7402704 | - | -0.047 | 2.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg08183547 | chr7:99971014 | PILRA | -0.1 | 2.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg09815212 | chr11:64899926 | SYVN1 | 0.11 | 2.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg24402372 | chr12:52997366 | - | 0.1 | 2.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg22775635 | chr6:6851367 | - | 0.11 | 2.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg02304370 | chr11:587926 | PHRF1 | 0.076 | 2.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg23084016 | chr10:45916904 | ALOX5 | -0.081 | 2.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg06712932 | chr12:94672432 | PLXNC1 | 0.066 | 2.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg06791501 | chr3:140962210 | PXYLP1 | 0.091 | 2.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg25536676 | chr1:55353327 | DHCR24 | -0.057 | 2.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg00520583 | chr16:30492903 | ITGAL | 0.065 | 2.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg14642045 | chr12:109538736 | UNG | -0.088 | 2.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg09739398 | chr11:47416886 | - | -0.078 | 2.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg22821472 | chr8:70743568 | SLCO5A1 | 0.048 | 2.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg11131902 | chr5:175084710 | HRH2 | -0.058 | 2.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg18732361 | chr12:6877080 | PTMS | -0.055 | 2.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg21027908 | chr1:35909835 | KIAA0319L | 0.09 | 2.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg08973191 | chr8:144894328 | SCRIB | 0.073 | 2.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg15740041 | chr16:87781336 | KLHDC4 | 0.044 | 2.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg07420027 | chr3:159705224 | IL12A;IL12A-AS1 | -0.09 | 2.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg21910329 | chr12:77631873 | - | -0.082 | 2.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg14647287 | chr4:6927183 | TBC1D14 | -0.12 | 2.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg01294862 | chr3:194882923 | XXYLT1 | -0.08 | 2.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg09530156 | chr11:69867139 | - | -0.095 | 2.8E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg16256243 | chr2:85648512 | - | -0.094 | 2.8E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg16082989 | chr19:42613682 | POU2F2 | 0.11 | 2.8E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg01016119 | chr3:56835282 | ARHGEF3 | -0.059 | 2.8E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg03956820 | chr17:80190154 | SLC16A3 | -0.092 | 2.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg16989977 | chr4:39611473 | SMIM14 | 0.075 | 2.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg17329534 | chr1:154980743 | ZBTB7B | -0.064 | 2.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg14769021 | chr3:39231122 | XIRP1 | -0.08 | 2.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg25978218 | chr1:15738732 | EFHD2 | -0.059 | 2.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg09244305 | chr9:135772446 | TSC1 | 0.07 | 2.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg15651928 | chr20:32290811 | PXMP4 | 0.087 | 2.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg24002003 | chr15:101668143 | - | -0.071 | 2.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg03574306 | chr16:85470662 | - | 0.058 | 3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg02261541 | chr16:4050315 | ADCY9 | -0.075 | 3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg21124952 | chr12:56544386 | - | 0.085 | 3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg03144189 | chr1:227734067 | - | 0.089 | 3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg02233071 | chr21:36181046 | RUNX1 | -0.052 | 3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg15735313 | chr17:10055497 | GAS7 | -0.06 | 3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg13210581 | chr11:29644815 | - | 0.047 | 3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg12838653 | chr15:95676215 | - | -0.058 | 3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg08260754 | chr19:36100919 | - | 0.063 | 3.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg25491122 | chr13:67801551 | PCDH9 | -0.045 | 3.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg24329397 | chr14:103781770 | - | -0.1 | 3.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg17574739 | chr19:39694993 | SYCN | 0.055 | 3.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg00502254 | chr1:12201600 | TNFRSF8 | 0.08 | 3.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg24687894 | chr20:62705934 | RGS19 | 0.11 | 3.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg17179557 | chr10:134918842 | GPR123 | -0.083 | 3.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg15042300 | chr20:42381469 | - | -0.055 | 3.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg27111756 | chr19:45899412 | PPP1R13L | 0.048 | 3.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg26170244 | chr15:65176353 | - | -0.062 | 3.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg13876756 | chr5:173360041 | CPEB4 | 0.065 | 3.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg10667834 | chr1:222807463 | MIA3 | -0.11 | 3.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg01404893 | chr16:89043547 | CBFA2T3 | -0.091 | 3.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg13263397 | chr1:169078711 | ATP1B1 | -0.064 | 3.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg11136886 | chr1:33609509 | - | 0.11 | 3.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg13413819 | chr2:43191888 | - | -0.1 | 3.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg01734180 | chr20:35922996 | MANBAL | 0.087 | 3.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg03526563 | chr15:68112070 | SKOR1 | 0.071 | 3.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg21066748 | chr19:46005805 | - | 0.082 | 3.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg08000432 | chr18:56642910 | ZNF532 | -0.03 | 3.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg00357074 | chr12:50046959 | FMNL3 | 0.11 | 3.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg17194270 | chr22:39759992 | SYNGR1 | 0.078 | 3.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg04577162 | chr7:73667397 | RFC2 | 0.099 | 3.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg17853961 | chr22:38388771 | POLR2F | 0.088 | 3.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg09384986 | chr10:76530805 | - | 0.058 | 3.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg04162032 | chr1:248902767 | LOC646627 | 0.085 | 3.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg18302637 | chr5:1254777 | TERT | -0.09 | 3.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg27020362 | chr5:138723394 | MGC29506 | -0.059 | 3.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg22851879 | chr2:30565225 | - | -0.076 | 3.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg16835398 | chr8:116837434 | - | -0.059 | 3.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg03362418 | chr22:50965563 | TYMP;SCO2 | -0.049 | 3.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg23627888 | chr10:6296323 | - | 0.096 | 3.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg12280276 | chr6:30117932 | - | 0.09 | 3.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg25763898 | chr2:102092013 | RFX8 | -0.078 | 3.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg00607627 | chr16:28995994 | LAT | -0.064 | 3.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg13059136 | chr11:2986541 | SNORA54;NAP1L4 | 0.083 | 3.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg13993688 | chr7:99774469 | GPC2;STAG3 | 0.094 | 3.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg20552513 | chr2:112390271 | - | 0.059 | 3.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg06202737 | chr2:128166279 | - | -0.057 | 3.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg16014651 | chr7:5435066 | TNRC18 | -0.13 | 3.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg12581512 | chr14:94422013 | ASB2 | -0.049 | 3.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg05713943 | chr13:97912352 | MBNL2 | -0.12 | 3.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg16625765 | chr16:29838413 | MVP | 0.073 | 3.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg03784625 | chr3:53214866 | PRKCD | 0.065 | 3.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg16755922 | chr17:80536214 | FOXK2 | 0.049 | 3.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg00089960 | chr12:122245655 | SETD1B | 0.086 | 3.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg07803149 | chr3:45068568 | CLEC3B | -0.066 | 3.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg13149979 | chr16:75139595 | ZNRF1 | -0.097 | 3.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg03722322 | chr2:42952939 | MTA3 | 0.11 | 3.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg02750243 | chr21:45507885 | TRAPPC10 | -0.13 | 3.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg22167400 | chr17:26633978 | FLJ40504 | 0.078 | 3.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg03550494 | chr3:187904960 | LPP | -0.065 | 3.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg13560312 | chr1:145449739 | NBPF20;NBPF10 | -0.098 | 3.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg22054137 | chr16:28545892 | - | -0.071 | 3.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg02917536 | chr6:149642754 | TAB2 | -0.049 | 3.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg10476712 | chr19:3411820 | NFIC | 0.13 | 3.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg01445100 | chr16:88103339 | BANP | 0.11 | 3.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg24154948 | chr12:66061959 | - | -0.1 | 3.8E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg21167905 | chr1:172505895 | C1orf9 | 0.049 | 3.8E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg09733639 | chr17:72458906 | - | -0.058 | 3.8E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg27496230 | chr1:18739521 | - | -0.075 | 3.8E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg06686712 | chr12:7033332 | ATN1 | 0.12 | 3.8E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg05858681 | chr22:18285408 | MICAL3 | -0.12 | 3.8E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg14600484 | chr1:110086412 | GPR61 | 0.065 | 3.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg17501210 | chr6:166970252 | RPS6KA2 | -0.06 | 3.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg12738940 | chr14:77521802 | LOC283575 | -0.088 | 3.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg15691367 | chr9:33165571 | B4GALT1-AS1;B4GALT1 | -0.069 | 3.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg23539753 | chr2:231280698 | SP100 | -0.061 | 3.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg17700392 | chr10:6215036 | PFKFB3 | -0.088 | 3.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg13130783 | chr12:113797418 | PLBD2 | 0.12 | 3.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg11860005 | chr22:32149125 | DEPDC5 | -0.12 | 3.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg04109382 | chr20:44007107 | SYS1-DBNDD2;TP53TG5 | 0.12 | 3.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg26923863 | chr4:1221838 | CTBP1 | -0.086 | 4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg02782753 | chr7:923058 | GET4 | 0.097 | 4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg13154880 | chr4:48486472 | SLC10A4 | 0.055 | 4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg20493633 | chr20:48565595 | RNF114 | 0.11 | 4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg23125716 | chr11:119489014 | - | 0.067 | 4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg03522245 | chr20:25566470 | NINL | 0.046 | 4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg27292079 | chr16:89044681 | CBFA2T3 | -0.11 | 4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg18724069 | chr5:39721760 | - | -0.062 | 4.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg06567290 | chr11:118900111 | SLC37A4 | -0.081 | 4.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg27212386 | chr1:38411997 | INPP5B | -0.11 | 4.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg08698795 | chr3:112338074 | CCDC80 | 0.075 | 4.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg12802677 | chr15:77288844 | PSTPIP1 | -0.056 | 4.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg07013698 | chr17:80174780 | - | -0.092 | 4.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg26341457 | chr11:72523885 | - | -0.059 | 4.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg05733016 | chr2:197951438 | ANKRD44 | 0.076 | 4.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg17362171 | chr12:1922255 | CACNA2D4 | -0.072 | 4.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg12129824 | chr14:91844449 | CCDC88C | -0.065 | 4.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg22820108 | chr12:125003218 | NCOR2 | -0.14 | 4.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg27057526 | chr14:92940131 | SLC24A4 | -0.087 | 4.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg00747647 | chr19:10045441 | OLFM2 | 0.036 | 4.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg02030454 | chr1:35250489 | GJB3 | 0.036 | 4.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg17836612 | chr17:76976357 | LGALS3BP | 0.082 | 4.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg22080856 | chr2:99158634 | INPP4A | 0.094 | 4.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg17839611 | chr17:47286802 | ABI3;GNGT2 | 0.12 | 4.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg15068842 | chr11:60677810 | - | 0.065 | 4.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg05343811 | chr14:75590896 | NEK9 | -0.057 | 4.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg00304631 | chr1:246132849 | SMYD3 | -0.08 | 4.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg01695510 | chr3:150886304 | MED12L | 0.061 | 4.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg20190405 | chr12:110691012 | - | 0.074 | 4.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg10205767 | chr9:130524835 | SH2D3C | -0.13 | 4.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg22953759 | chr5:10632397 | ANKRD33B | -0.053 | 4.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg19713585 | chr16:2298791 | ECI1 | -0.1 | 4.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg17007896 | chr11:69261044 | - | -0.12 | 4.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg00013733 | chr19:1423273 | DAZAP1 | 0.062 | 4.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg07884764 | chr11:64107517 | CCDC88B | 0.05 | 4.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg02527961 | chr3:187681648 | - | -0.071 | 4.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg14849578 | chr12:125282480 | SCARB1 | 0.077 | 4.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg02064830 | chr19:17637930 | FAM129C | 0.097 | 4.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg08267072 | chr14:39739199 | CTAGE5 | -0.054 | 4.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg02694449 | chr6:42679734 | PRPH2 | 0.074 | 4.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg23322640 | chr6:111675295 | REV3L | 0.066 | 4.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg17874802 | chr12:6745691 | LPAR5 | 0.12 | 4.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg25130381 | chr1:27440721 | SLC9A1 | 0.055 | 4.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg15863211 | chr3:58185721 | DNASE1L3 | 0.097 | 4.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg25316512 | chr12:7032991 | ATN1 | 0.13 | 4.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg02915275 | chr3:18459048 | SATB1 | 0.068 | 4.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg04774822 | chr11:71165839 | NADSYN1 | 0.11 | 4.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg18783296 | chr15:91428131 | FES | -0.1 | 4.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg24391912 | chr15:100259320 | - | -0.058 | 4.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg05850338 | chr17:79933123 | - | 0.075 | 4.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg16028001 | chr11:29350553 | - | -0.049 | 4.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg06682371 | chr3:32291082 | CMTM8 | -0.056 | 4.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg17451941 | chr1:236254344 | - | -0.088 | 4.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg26955963 | chr2:8466005 | LINC00299 | 0.082 | 4.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg27335943 | chr5:76283327 | - | 0.096 | 4.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg08738516 | chr10:126408016 | FAM53B | 0.04 | 4.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg24312520 | chr17:40489584 | STAT3 | 0.057 | 4.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg22971501 | chr19:11199476 | LDLR | -0.053 | 4.8E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg10901780 | chr1:55330824 | DHCR24 | 0.097 | 4.8E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg24190664 | chr17:71258624 | CPSF4L | 0.088 | 4.8E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg18587465 | chr2:152784175 | CACNB4 | -0.11 | 4.8E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg19574915 | chr15:89195555 | ISG20 | 0.048 | 4.8E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg04339462 | chr14:100028196 | CCDC85C | 0.069 | 4.8E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg08128690 | chr9:75748226 | - | -0.058 | 4.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg24099565 | chr11:3058478 | CARS | 0.091 | 4.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg10110288 | chr5:55274030 | IL6ST | 0.068 | 4.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg23606722 | chr12:133319848 | ANKLE2 | 0.068 | 4.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg03295554 | chr11:128395450 | ETS1 | -0.045 | 4.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg22331200 | chr17:56355362 | MPO | -0.14 | 4.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg11454468 | chr3:142569221 | PCOLCE2 | -0.054 | 4.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg04515132 | chr3:53787670 | CACNA1D | 0.049 | 4.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg21271423 | chr19:7733642 | RETN | 0.07 | 4.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg10091025 | chr3:187454376 | BCL6 | -0.096 | 4.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg10575067 | chr19:39896215 | ZFP36 | 0.058 | 4.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg14930341 | chr6:43082234 | PTK7 | -0.081 | 5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg08429605 | chr17:71258613 | CPSF4L | 0.081 | 5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg00861847 | chr7:69735590 | AUTS2 | -0.1 | 5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg27102892 | chr14:75791837 | - | 0.092 | 5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg13264209 | chr21:37888745 | CLDN14 | 0.061 | 5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg23330903 | chr16:87781501 | KLHDC4 | 0.05 | 5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg07068382 | chr6:36947277 | MTCH1 | 0.067 | 5.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg22094797 | chr17:47286654 | GNGT2;ABI3 | 0.084 | 5.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg22015766 | chr6:34624127 | C6orf106 | -0.052 | 5.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg01381586 | chr2:10587627 | ODC1;SNORA80B | 0.042 | 5.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg03945538 | chr1:173447427 | PRDX6 | -0.12 | 5.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg12166711 | chr15:63666955 | CA12 | -0.081 | 5.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg16264214 | chr5:10618486 | ANKRD33B | 0.051 | 5.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg11969813 | chr17:79816559 | P4HB | 0.061 | 5.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg21566642 | chr2:233284661 | - | -0.057 | 5.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg04973995 | chr10:74057977 | - | -0.051 | 5.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg04426101 | chr9:5339864 | RLN1 | -0.058 | 5.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg04110886 | chr1:10675575 | PEX14 | 0.053 | 5.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg21932513 | chr1:17751974 | RCC2 | 0.079 | 5.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg16911564 | chr6:30574601 | PPP1R10 | 0.081 | 5.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg14338521 | chr11:3147867 | OSBPL5 | -0.1 | 5.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg05041552 | chr3:53137909 | RFT1 | 0.08 | 5.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg26487322 | chr13:79224394 | RNF219 | -0.085 | 5.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg12311593 | chr5:82789875 | VCAN | -0.093 | 5.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg01787382 | chr3:169041586 | MECOM | -0.056 | 5.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg01837280 | chr11:18549289 | TSG101 | -0.062 | 5.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg15079315 | chr20:4981089 | SLC23A2 | -0.049 | 5.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg05776323 | chr1:161165053 | ADAMTS4 | 0.067 | 5.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg18120259 | chr6:43894639 | LOC100132354 | -0.092 | 5.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg21883904 | chr7:2596713 | BRAT1 | 0.079 | 5.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg13123009 | chr6:31681882 | LY6G6E;LY6G6D | 0.09 | 5.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg07960624 | chr8:119208486 | SAMD12 | -0.052 | 5.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg19997773 | chr5:32445814 | ZFR | 0.093 | 5.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg18954700 | chr10:124220854 | HTRA1 | -0.041 | 5.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg17111845 | chr22:37100540 | - | 0.034 | 5.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg18987823 | chr2:28863269 | PLB1 | 0.085 | 5.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg07226581 | chr9:37859354 | DCAF10 | 0.049 | 5.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg13134916 | chr12:25707564 | IFLTD1 | -0.07 | 5.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg10065049 | chr7:86856126 | - | 0.089 | 5.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg11613109 | chr19:18655521 | FKBP8 | 0.068 | 5.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg10068491 | chr16:3183125 | - | 0.07 | 5.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg25237646 | chr6:6007641 | NRN1 | 0.061 | 5.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg12728465 | chr7:99612529 | ZKSCAN1 | 0.085 | 5.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg02722539 | chr2:68654573 | - | -0.054 | 5.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg05796981 | chr1:228275734 | ARF1 | -0.061 | 5.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg20460366 | chr20:44934032 | - | 0.067 | 5.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg00608540 | chr5:180627973 | TRIM7 | 0.12 | 5.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg05579598 | chr16:88989069 | CBFA2T3 | -0.075 | 5.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg20735563 | chr6:144966223 | UTRN | 0.058 | 5.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg04037750 | chr2:220472938 | STK11IP | 0.1 | 5.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg01568899 | chr2:12454300 | LOC100506457 | 0.058 | 5.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg08738297 | chr7:144539618 | - | -0.069 | 5.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg24295963 | chr6:35681420 | FKBP5 | 0.11 | 5.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg03710955 | chr22:39265394 | CBX6 | -0.099 | 5.8E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg11245243 | chr19:48744484 | CARD8 | 0.067 | 5.8E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg08086084 | chr19:55948549 | SHISA7 | -0.031 | 5.8E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg18684887 | chr19:46078161 | OPA3 | 0.12 | 5.8E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg00965203 | chr16:85513747 | - | 0.11 | 5.8E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg23086613 | chr1:117047419 | - | -0.056 | 5.8E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg16247408 | chr11:65256389 | - | -0.076 | 5.8E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg03008741 | chr16:69148573 | HAS3 | 0.088 | 5.8E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg17001958 | chr7:1191882 | - | 0.058 | 5.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg27097542 | chr16:11706435 | - | -0.12 | 5.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg25705792 | chr21:35320017 | LINC00649 | -0.083 | 5.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg20989280 | chr1:160343735 | - | 0.083 | 5.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg16265859 | chr1:19401069 | UBR4 | 0.1 | 5.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg03497059 | chr11:3147966 | OSBPL5 | -0.091 | 5.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg21291385 | chr21:35448215 | MRPS6;SLC5A3 | -0.066 | 5.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg16389705 | chr5:139051131 | CXXC5 | -0.085 | 6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg25338563 | chr8:103669495 | - | -0.055 | 6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg07491324 | chr9:124721037 | TTLL11 | -0.05 | 6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg03598868 | chr6:170195479 | LINC00242;LINC00574 | -0.068 | 6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg00061632 | chr17:36979013 | CWC25 | 0.13 | 6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg05264101 | chr17:75880308 | FLJ45079 | 0.14 | 6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg11807844 | chr13:40362473 | COG6 | -0.075 | 6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg16504531 | chr9:34124346 | DCAF12 | -0.075 | 6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg04509882 | chr3:184038317 | EIF4G1 | 0.074 | 6.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg22950899 | chr19:5253997 | PTPRS | 0.063 | 6.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg05596126 | chr3:197184641 | - | -0.11 | 6.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg18437669 | chr3:50096700 | RBM6 | 0.072 | 6.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg04010861 | chr4:8349838 | - | 0.042 | 6.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg06722639 | chr14:23624377 | SLC7A8 | 0.042 | 6.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg09530861 | chr6:107776494 | PDSS2 | 0.067 | 6.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg02464519 | chr15:41158367 | - | -0.066 | 6.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg12818967 | chr6:111550921 | - | -0.074 | 6.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg26495625 | chr1:192522020 | - | -0.058 | 6.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg13626571 | chr9:129879787 | ANGPTL2;RALGPS1 | 0.12 | 6.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg06645608 | chr12:56975326 | RBMS2 | -0.096 | 6.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg08937734 | chr1:19422904 | UBR4 | 0.092 | 6.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg13575087 | chr2:70884007 | - | 0.095 | 6.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg02747254 | chr16:29938183 | KCTD13 | -0.076 | 6.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg27317813 | chr12:4398508 | CCND2 | -0.083 | 6.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg14654385 | chr11:63973006 | FERMT3 | -0.12 | 6.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg18298966 | chr1:28650718 | - | 0.073 | 6.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg08470588 | chr6:14758733 | - | -0.096 | 6.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg04243215 | chr13:48716867 | - | 0.07 | 6.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg15343669 | chr10:5333687 | - | -0.057 | 6.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg04324917 | chr16:87734877 | LOC100129637 | 0.085 | 6.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg13911577 | chr3:40115005 | MYRIP | 0.038 | 6.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg24432450 | chr4:187422895 | - | -0.082 | 6.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg13166622 | chr3:150904863 | MED12L | 0.054 | 6.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg04136321 | chr6:32093933 | ATF6B | 0.1 | 6.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg10279433 | chr14:73176084 | DPF3 | -0.1 | 6.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg06600229 | chr1:153661410 | NPR1 | 0.11 | 6.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg18697571 | chr5:96743054 | - | -0.07 | 6.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg02203067 | chr16:87866800 | SLC7A5 | 0.099 | 6.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg09029192 | chr17:76015204 | TNRC6C | 0.095 | 6.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg27094813 | chr1:212624500 | - | 0.1 | 6.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg24337975 | chr2:233876260 | NGEF | 0.087 | 6.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg22328249 | chr9:92080039 | SEMA4D | -0.054 | 6.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg09890930 | chr12:56149396 | SARNP | -0.086 | 6.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg20623644 | chr1:151237347 | PSMD4 | 0.088 | 6.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg08638180 | chr16:67283238 | SLC9A5 | 0.11 | 6.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg11270206 | chr2:220264849 | - | 0.11 | 6.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg15988232 | chr3:47621127 | CSPG5 | 0.067 | 6.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg19111262 | chr1:159916126 | IGSF9 | -0.095 | 6.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg02159619 | chr3:71132959 | FOXP1 | 0.11 | 6.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg12128467 | chr9:124116096 | STOM | -0.084 | 6.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg13363801 | chr13:111355635 | CARS2 | -0.09 | 6.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg01366692 | chr11:65291439 | SCYL1 | 0.097 | 6.8E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg11859419 | chr14:51265001 | NIN | 0.095 | 6.8E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg09430705 | chr12:6831052 | - | 0.058 | 6.8E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg15551881 | chr9:123688715 | TRAF1 | 0.055 | 6.8E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg26885268 | chr7:149389941 | - | 0.059 | 6.8E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg01495099 | chr20:36872322 | KIAA1755 | -0.05 | 6.8E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg18522464 | chr1:9253044 | - | 0.11 | 6.8E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg24720336 | chr1:151170427 | PIP5K1A | -0.047 | 6.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg06795340 | chr9:107546652 | ABCA1 | -0.066 | 6.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg14601313 | chr3:30485453 | - | -0.058 | 6.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg00050496 | chr12:110211701 | MGC14436 | 0.059 | 6.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg12645876 | chr15:102194127 | TARSL2 | 0.068 | 6.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg03819286 | chr16:4673974 | MGRN1 | 0.1 | 6.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg11860233 | chr19:12827923 | TNPO2 | 0.064 | 6.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg12984893 | chr10:134353627 | INPP5A | -0.075 | 6.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg08833031 | chr17:10581818 | - | 0.063 | 7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg08283315 | chr4:15133343 | LOC101929095 | 0.03 | 7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg06052053 | chr6:38123146 | - | -0.095 | 7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg26717696 | chr14:24599765 | FITM1 | 0.085 | 7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg16167174 | chr22:41215243 | SLC25A17 | 0.069 | 7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg02436098 | chr19:4640159 | TNFAIP8L1 | -0.061 | 7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg25844708 | chr13:53270248 | - | -0.056 | 7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg18458509 | chr11:2920189 | SLC22A18AS;SLC22A18 | -0.061 | 7.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg22361433 | chr13:94969674 | GPC6 | 0.052 | 7.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg16291589 | chr20:6023178 | LRRN4 | 0.074 | 7.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg08311322 | chr12:116716330 | MED13L | -0.083 | 7.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg06002198 | chr10:6187994 | PFKFB3 | -0.054 | 7.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg03627372 | chr19:4559830 | SEMA6B | -0.12 | 7.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg18436544 | chr13:24825781 | SPATA13 | 0.1 | 7.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg11158057 | chr1:239549798 | - | -0.05 | 7.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg09254264 | chr12:132891706 | GALNT9 | 0.063 | 7.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg11120551 | chr1:146713996 | CHD1L | -0.067 | 7.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg13479613 | chr3:63805121 | C3orf49 | -0.071 | 7.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg14200470 | chr9:38074955 | - | 0.1 | 7.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg27093546 | chr12:25404596 | KRAS | -0.068 | 7.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg13723694 | chr11:366487 | - | -0.099 | 7.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg06035528 | chr9:35650778 | SIT1 | 0.12 | 7.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg18840187 | chr4:169608898 | PALLD | 0.081 | 7.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg01602822 | chr3:56951917 | ARHGEF3 | 0.063 | 7.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg14537712 | chr5:175579473 | LOC643201 | 0.066 | 7.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg14764459 | chr12:107160223 | LOC100287944 | 0.1 | 7.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg03800048 | chr1:231476388 | SPRTN | 0.06 | 7.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg14185446 | chr19:55834866 | TMEM150B | -0.13 | 7.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg25358033 | chr12:113714589 | TPCN1 | 0.092 | 7.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg05455036 | chr1:202828149 | - | -0.099 | 7.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg17025698 | chr17:27233965 | PHF12 | 0.09 | 7.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg12002417 | chr7:128863549 | AHCYL2 | 0.073 | 7.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg09022430 | chr2:47800047 | - | -0.08 | 7.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg17132054 | chr10:2218871 | - | -0.067 | 7.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg01120733 | chr19:19080651 | - | -0.056 | 7.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg20646141 | chr1:145433673 | NBPF20;NBPF10 | -0.093 | 7.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg15728672 | chr8:89189971 | MMP16 | -0.057 | 7.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg25215771 | chr19:52848753 | ZNF610 | -0.081 | 7.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg22345623 | chr9:125050297 | MRRF | 0.053 | 7.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg20133249 | chr1:6524448 | TNFRSF25 | -0.094 | 7.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg18759809 | chr10:30598335 | - | 0.11 | 7.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg26248007 | chr13:48730782 | - | 0.054 | 7.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg11928146 | chr2:19546630 | - | 0.13 | 7.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg04655243 | chr5:145406206 | SH3RF2 | -0.046 | 7.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg07725183 | chr6:32190556 | NOTCH4 | 0.067 | 7.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg23324403 | chr8:19058399 | LOC100128993 | -0.048 | 7.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg10402995 | chr1:248903325 | LOC646627 | 0.11 | 7.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg19543782 | chr10:35775490 | CCNY | 0.088 | 7.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg19781843 | chr1:36028061 | NCDN | -0.13 | 7.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg07781445 | chr17:2886250 | RAP1GAP2 | 0.1 | 7.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg04104358 | chr11:12180973 | MICAL2 | 0.069 | 7.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg23426633 | chr6:31597831 | BAT2 | 0.053 | 7.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg23206115 | chr6:158066900 | ZDHHC14 | -0.12 | 7.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg07058694 | chr12:111909145 | ATXN2 | 0.09 | 7.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg01125010 | chr17:76134099 | TMC8 | 0.061 | 7.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg14800658 | chr13:98599746 | - | -0.067 | 7.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg17739917 | chr17:38477572 | RARA | 0.063 | 7.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg23839288 | chr17:79126509 | AATK | -0.06 | 7.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg10561735 | chr19:12856517 | ASNA1 | 0.1 | 7.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg22475728 | chr3:169281400 | MECOM | 0.11 | 8E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg09273716 | chr20:35494835 | - | 0.094 | 8E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg14796050 | chr4:7637373 | SORCS2 | -0.088 | 8E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg06381803 | chr19:46119475 | EML2 | 0.041 | 8.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg01218903 | chr17:74911481 | MGAT5B | -0.056 | 8.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg03181006 | chr4:62328486 | - | -0.05 | 8.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg15444978 | chr14:103851370 | MARK3 | 0.067 | 8.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg20395094 | chr8:97779438 | CPQ | 0.057 | 8.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg05714960 | chr1:25291695 | RUNX3 | 0.077 | 8.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg18133477 | chr20:33293445 | TP53INP2 | 0.12 | 8.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg22970959 | chr10:14647077 | FAM107B | -0.048 | 8.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg09844399 | chr14:25526434 | - | -0.1 | 8.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg00192882 | chr17:19291120 | MFAP4 | -0.12 | 8.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg07452625 | chr16:89598568 | SPG7 | 0.073 | 8.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg21612138 | chr1:116211578 | VANGL1 | -0.071 | 8.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg19458497 | chr11:63403371 | ATL3 | 0.12 | 8.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg15143725 | chr13:111829925 | ARHGEF7 | -0.082 | 8.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg06114546 | chr16:88645532 | ZC3H18 | 0.091 | 8.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg05778738 | chr3:107308392 | BBX | 0.053 | 8.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg08794544 | chr11:45825518 | SLC35C1 | -0.1 | 8.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg06991118 | chr18:9117348 | NDUFV2 | -0.05 | 8.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg23173175 | chr13:31293165 | ALOX5AP | -0.11 | 8.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg00509451 | chr11:64811775 | SAC3D1 | 0.088 | 8.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg23392390 | chr17:19649191 | ALDH3A1 | 0.096 | 8.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg04315689 | chr2:74198896 | DGUOK-AS1 | 0.092 | 8.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg21025681 | chr1:11134131 | EXOSC10 | 0.054 | 8.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg16782885 | chr8:11541421 | - | 0.04 | 8.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg05392293 | chr10:13911331 | FRMD4A | 0.083 | 8.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg00659453 | chr17:20208448 | SPECC1 | 0.096 | 8.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg04031361 | chr1:236557758 | EDARADD | 0.051 | 8.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg20849146 | chr7:17314686 | - | -0.07 | 8.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg16305292 | chr8:142219965 | - | 0.084 | 8.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg13264822 | chr7:137565290 | CREB3L2 | 0.067 | 8.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg05046068 | chr22:38241182 | ANKRD54;MIR658 | 0.073 | 8.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg00139947 | chr8:144403371 | TOP1MT | 0.04 | 8.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg20387329 | chr20:55710975 | - | -0.091 | 8.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg18438647 | chr18:5841833 | - | -0.05 | 8.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg00302379 | chr14:65539151 | MAX | 0.063 | 8.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg26233914 | chr16:31366536 | ITGAX | -0.052 | 8.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg22051853 | chr7:2647589 | IQCE | -0.12 | 8.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg13474790 | chr12:69166745 | - | 0.055 | 8.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg04813175 | chr9:7977013 | - | -0.079 | 8.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg14634473 | chr10:23105437 | - | -0.078 | 8.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg23927426 | chr19:14895717 | - | -0.063 | 8.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg22581352 | chr8:142219329 | - | -0.12 | 8.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg18696027 | chr15:45002597 | B2M | -0.057 | 8.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg11555919 | chr1:84763932 | SAMD13 | 0.072 | 8.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg11177333 | chr3:195857752 | - | 0.12 | 8.8E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg08331261 | chr9:138778684 | CAMSAP1 | 0.13 | 8.8E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg15032960 | chr20:56888536 | RAB22A | 0.068 | 8.8E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg10724969 | chr3:33705968 | CLASP2 | -0.061 | 8.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg11861474 | chr17:78013825 | CCDC40 | 0.08 | 8.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg14449358 | chr14:23357321 | - | 0.13 | 8.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg17661756 | chr9:10786455 | - | -0.052 | 8.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg09174829 | chr1:42631405 | GUCA2A | 0.068 | 8.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg10580599 | chr14:39702142 | MIA2 | -0.06 | 9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg11459094 | chr1:203264923 | - | 0.097 | 9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg00301180 | chr17:74126498 | - | 0.07 | 9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg24350568 | chr15:91428139 | FES | -0.1 | 9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg21681017 | chr14:101146259 | - | 0.062 | 9.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg06893389 | chr14:37117018 | - | -0.047 | 9.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg27513339 | chr3:9904903 | - | -0.11 | 9.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg21598248 | chr2:232047374 | - | 0.078 | 9.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg02727150 | chr12:116774745 | - | -0.066 | 9.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg11752250 | chr14:68089471 | ARG2 | -0.053 | 9.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg26485825 | chr18:21452895 | LAMA3 | 0.093 | 9.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg19647567 | chr5:176935305 | DOK3 | -0.12 | 9.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg13572071 | chr1:23707912 | TCEA3 | 0.083 | 9.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg03692563 | chr11:31846414 | - | 0.056 | 9.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg26893685 | chr6:2523615 | - | -0.06 | 9.1E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg12047815 | chr3:142575982 | PCOLCE2 | -0.064 | 9.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg00796661 | chr1:116856120 | - | 0.066 | 9.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg25575970 | chr1:234379305 | SLC35F3 | -0.056 | 9.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg14151953 | chr13:110219875 | - | 0.049 | 9.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg17100575 | chr7:135368563 | SLC13A4 | 0.07 | 9.2E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg14900902 | chr1:172616593 | - | 0.089 | 9.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg00057449 | chr1:45185162 | C1orf228 | 0.12 | 9.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg23064281 | chr6:13537911 | - | 0.068 | 9.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg03964940 | chr6:144477779 | STX11 | -0.045 | 9.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg22794504 | chr19:5173258 | - | 0.041 | 9.3E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg24996930 | chr14:77229233 | VASH1 | 0.059 | 9.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg21747817 | chr17:7120354 | ACADVL;DLG4 | -0.088 | 9.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg17107472 | chr3:50611699 | HEMK1 | 0.13 | 9.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg18496235 | chr16:25248855 | ZKSCAN2 | 0.057 | 9.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg04674060 | chr17:7792063 | CHD3 | 0.12 | 9.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg18030453 | chr3:45506216 | LARS2 | 0.1 | 9.4E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg16336494 | chr6:151188259 | MTHFD1L | -0.059 | 9.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg05327106 | chr3:194942344 | XXYLT1 | -0.096 | 9.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg06154315 | chr12:113436953 | OAS2 | 0.12 | 9.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg07171027 | chr4:133368947 | - | -0.083 | 9.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg19432791 | chr3:45894556 | LZTFL1 | 0.053 | 9.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg00927449 | chr4:77198262 | FAM47E;FAM47E-STBD1 | -0.059 | 9.5E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg07744435 | chr11:67768362 | UNC93B1 | 0.064 | 9.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg21407367 | chr8:134188492 | - | 0.076 | 9.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg14707566 | chr15:96669301 | - | -0.062 | 9.6E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg01437204 | chr1:202130344 | PTPN7 | -0.05 | 9.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg12729822 | chr1:26855454 | RPS6KA1 | 0.077 | 9.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg17724900 | chr2:60545388 | - | 0.067 | 9.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg19285358 | chr15:74928240 | EDC3 | 0.14 | 9.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg25445101 | chr17:26878566 | UNC119 | -0.11 | 9.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg11350586 | chr17:70115862 | SOX9 | 0.04 | 9.7E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg07472953 | chr17:38170906 | CSF3 | 0.077 | 9.8E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg11883423 | chr4:153273933 | FBXW7 | 0.067 | 9.8E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg19040264 | chr12:122760981 | CLIP1 | -0.057 | 9.8E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg19747961 | chr16:2286378 | DNASE1L2 | -0.09 | 9.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg16000331 | chr22:42230138 | SREBF2 | -0.057 | 9.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg02107801 | chr20:31482551 | - | 0.088 | 9.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg16353907 | chr10:1088606 | IDI1;IDI2-AS1 | 0.048 | 9.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg16125214 | chr1:9751353 | PIK3CD | 0.077 | 9.9E-05 |
Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Type 2 Diabetes (Self-report) | Whole blood | Fully-adjusted model | 14350 | cg00472758 | chr16:2552820 | TBC1D24 | 0.084 | 9.9E-05 |
Download
*this tab-deliminated tsv file contains the full set of associations and variables, i.e. those in the downloadable catalog.